RecruitingNCT06760832

How to Optimize Enteral Feeding of the Full Enteral Feeding Preterm Infant

How to Optimize Enteral Feeding of the Full Enteral Feeding Preterm Infant: Evaluation of Different Gastric Tube Management Practices


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

50 participants

Start Date

Jul 21, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Very low-birth-weight premature infants (VLBWs) are fed via nasal or oro-gastric tube for a long time because of the physiological inability to coordinate swallowing, sucking, and breathing until at least 34 weeks of gestational age. Both bolus and continuous feeding modes are widely described in the literature; both modes have specific risks and benefits, and there is no evidence in the literature as to which mode is best in terms of tolerance and adverse effects. To date, the characteristics of enteral feeding that are associated with better feeding tolerance and fewer adverse effects have not been uniquely documented. There are currently no data in the literature directly comparing different modes of enteral feeding tube management in the preterm VLBW infant. Therefore, our study aims to evaluate different modes of enteral feeding tube management (extemporaneous vs. permanent introduction/removal and oral vs. nasal introduction route) in order to optimize enteral feeding management of the VLBW infant.


Eligibility

Inclusion Criteria4

  • Gestational Age <32 weeks and/or neonatal weight <1500 g
  • Achievement of full enteral feeding (150 ml/kg/day of milk)
  • Exclusive feeding of human milk (breast and/or bank)
  • Informed consent signed by parent or legal guardian

Exclusion Criteria2

  • Need for invasive ventilatory support
  • Congenital malformations affecting the gastrointestinal tract

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bolgona, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06760832


Related Trials